Scientists gave a standing ovation for daraxonrasib, a drug that almost doubled survival times for p...
Treating pancreatic tumours may have revealed cancer’s master switch
Scientists gave a standing ovation for daraxonrasib, a drug that almost doubled survival times for pancreatic cancer patients and could treat millions with...
Author: The Economist
Read Original Article